相关实验视频

Updated: May 16, 2025

Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications

Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications

Published on: January 27, 2014

将氨基-3,5-迪亚诺皮里丁基架从腺素受体连接体重新定位为碳酸无水酶激活剂

Erica Vigiani¹, Alessandro Bonardi², Daniela Catarzi¹

¹Dipartimento di Neuroscienze, Psicologia, Area del Farmaco e Salute del Bambino, Sezione di Farmaceutica e Nutraceutica, Università degli Studi di Firenze, Via U. Schiff, 6, 50019, Sesto Fiorentino, Italy.

European journal of medicinal chemistry

|April 5, 2025

概括

新的伊米达衍生物激活了关键的人类碳酸酶 (hCA) 酶,为大脑疾病提供了潜在的药理工具. 化合物17在中枢神经系统应用中显示出有前途的类似药物的特性.

科学领域:

生物化学生物化学
药理学药理学是指药理学的学科.
药用化学医学化学

背景情况:

人类碳酸无水酶 (hCA) 是关键的酶,参与生理过程,包括大脑功能.
对hCA活性的失调与精神病和神经退行性疾病有关.
开发选择性hCA激活剂 (CAAs) 对于创建新型治疗策略至关重要.

研究的目的:

重新利用含有伊米达的氨基-3,5-迪亚诺皮里丁作为特定的人类碳酸酶异酶 (hCA I,II,VA,VII) 的激活剂.
确定新的CAAs作为药理学工具,用于调查CAAs在神经和精神疾病中的作用.
评估这些化合物的类似药物的特性和潜在的治疗应用.

主要方法:

选含有伊米达的氨基-3,5-迪亚诺皮里丁,以激活hCA I,II,VA和VII.
确定活性化合物的结合亲和度 (K_A值).
使用X射线和同质模型对化合物14的结合方式进行了无分析.
在ADME属性的计算中,以评估药物相似性和药物动力学概况.

主要成果:

化合物对hCA II无活性,类似于参考激活剂组胺.
化合物13和24分别在hCA VII和I处显示了最低的K_A值.
衍生品14和17在低微分子范围内表现出平衡且有效的hCA I,VA和VII激活.
化合物17表现出有利的ADME特性,包括高口服可用性,肠道血液屏障透性和血液-大脑屏障 (BBB) 透潜力.

结论:

重新使用的伊米达衍生物对特定的hCA异酶具有选择性激活特征,这些异酶与大脑功能有关.
化合物17是作为药理学工具进一步开发的有希望的候选者,因为它具有平衡的hCA激活和有利的类似药物的特性.
这些发现支持针对HCAs治疗精神病和神经退行性疾病的潜力.

关键词:

氨基-3,5-迪亚诺皮里迪因.碳酸无水酶激活剂碳酸无水酶激活剂与认知相关的疾病认知相关的疾病记忆障碍疾病记忆障碍疾病重新利用方法是重用方法.

更多相关视频

Activation and Conjugation of Soluble Polysaccharides using 1-Cyano-4-Dimethylaminopyridine Tetrafluoroborate CDAP

Activation and Conjugation of Soluble Polysaccharides using 1-Cyano-4-Dimethylaminopyridine Tetrafluoroborate CDAP

Published on: June 14, 2021

Preparation of Enantiopure Non-Activated Aziridines and Synthesis of Biemamide B, D, and epiallo-Isomuscarine

Preparation of Enantiopure Non-Activated Aziridines and Synthesis of Biemamide B, D, and epiallo-Isomuscarine

Published on: June 13, 2022

相关概念视频

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...

Adrenergic Agonists: Indirect-Acting Agents

Adrenergic Agonists: Indirect-Acting Agents

Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...

Adrenergic Agonists: Direct-Acting Agents

Adrenergic Agonists: Direct-Acting Agents

Drugs that mimic the action of endogenous catecholamines like noradrenaline and adrenaline are called adrenergic agonists or sympathomimetics. Based on their mechanism of action, sympathomimetics can be classified as direct-, indirect-, or mixed-acting sympathomimetics. Direct-acting adrenergic agonists activate adrenoceptors without affecting presynaptic neurons, making them independent of neuronal catecholamine-depleting agents like reserpine and guanethidine.
These agents can be classified...

Transducer Mechanism: Enzyme-Linked Receptors

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:

Preparation of Amines: Reductive Amination of Aldehydes and Ketones

Preparation of Amines: Reductive Amination of Aldehydes and Ketones

Carbonyl compounds and primary amines undergo reductive amination first to produce imines, followed by secondary amines in the same reaction mixture, using selective reducing agents like sodium cyanoborohydride or sodium triacetoxyborohydride. Reductive amination produces different degrees of substitution of amines depending on the starting amine substrate.

Allosteric Proteins-ATCase

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...